Bimatoprost/Timolol Versus Travoprost/Timolol

Kasr El Aini Hospital80 enrolled

Overview

The purpose of this study is to compare 2 fixed combination medications in intraocular pressure lowering.

PURPOSE: To compare the efficacy of bimatoprost/timolol (BTFC) or travoprost/timolol (TTFC) fixed combinations on intraocular pressure (IOP) reduction in an Egyptian population. METHODS: Patients with primary open angle glaucoma (POAG) were randomized to receive either BTFC or TTFC. IOPs were measured at baseline, 2 weeks, and 1, 2, 4, and 6 months. The primary outcome measures were the mean change in IOP from baseline

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Glaucoma

Interventions

GanfortDRUG

Bimatoprost/Timolol fixed combination

DuotravDRUG

Fixed combination of Travoprost and Timolol

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Glaucoma Exclusion Criteria: * No other ocular diseases

Locations (1)

Kasr El Aini Hospital

Cairo, Egypt

Outcomes

Primary Outcomes

Percentage of drop of intraocular pressures from baseline.

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.